Glimepiride 1 mg Australia

Description

Introduction

Glimepiride 1 mg Australia is an oral tablet identified as containing 1 mg of the active ingredient glimepiride. Glimepiride lowers blood glucose in type 2 diabetes when measures such as diet and physical activity do not provide adequate control. It is used as part of a broader diabetes management plan.

The supplied tablets’ appearance, inactive ingredients and exact storage requirements should be checked on the pack or with a pharmacist, as these details can differ between products.

What Is It?

Glimepiride belongs to a group of medicines called sulfonylureas. It is taken by mouth and acts on the body’s insulin release. The 1 mg strength describes the amount of active ingredient in each tablet.

Tablet strength does not establish an individual dose or treatment schedule. A healthcare professional determines whether glimepiride is appropriate in light of blood glucose results, other medicines and relevant health conditions.

How Does It Work?

Glimepiride acts mainly by stimulating insulin release from beta cells in the pancreas. Insulin helps move glucose from the blood into body tissues. Increased insulin release can therefore lower blood glucose in people with type 2 diabetes.

This action also creates a risk of blood glucose falling too low, known as hypoglycaemia. Missed meals, fasting, changes in activity and some other medicines can increase that risk. Monitoring helps a healthcare professional assess the response to treatment.

Common Uses

Glimepiride is used to manage type 2 diabetes when diet, exercise and weight management alone have not achieved adequate blood glucose control. A clinician may use it alone or with another diabetes medicine if combination treatment is appropriate.

Glimepiride is not a treatment for type 1 diabetes, diabetic ketoacidosis or diabetic coma. It does not replace the lifestyle measures and monitoring that form part of diabetes care.

Available Strengths

• Glimepiride 1 mg Australia
• Glimepiride 3 mg Australia
• Glimepiride 4 mg Australia

Key Features

• Contains glimepiride at a stated strength of 1 mg per tablet.
• Comes in an oral tablet formulation.
• Belongs to the sulfonylurea class of blood glucose lowering medicines.
• Acts mainly by increasing insulin release from pancreatic beta cells.
• Is used within a type 2 diabetes management plan that includes lifestyle measures and monitoring.

Benefits

• Glimepiride has an established blood glucose lowering effect in type 2 diabetes.
• Changes in blood glucose and HbA1c can be used to assess the response to treatment.
• Its tablet form provides an oral treatment option when a healthcare professional considers a sulfonylurea appropriate.

The degree of blood glucose lowering varies. Treatment decisions also account for possible harms, especially hypoglycaemia.

Possible Side Effects

• Hypoglycaemia can cause sweating, hunger, shaking, dizziness, headache, confusion or difficulty concentrating. It can sometimes be severe or recur.
• Nausea, vomiting, diarrhoea, abdominal discomfort or changes in taste may occur.
• Temporary visual disturbance can occur when blood glucose levels change.
• Rash, itching or hives have been reported. A serious allergic reaction is possible.
• Changes affecting liver function or blood cells have been reported. Weight gain may also occur.

Severe or prolonged hypoglycaemia, loss of consciousness, breathing difficulty or signs of a serious allergic reaction require urgent medical attention. A healthcare professional can explain how to recognise and manage low blood glucose.

Precautions

• Tell a healthcare professional about any previous reaction to glimepiride, another sulfonylurea or a sulfonamide medicine.
• Discuss kidney or liver disease before treatment. Severe impairment may make glimepiride inappropriate.
• Irregular meals, fasting, changes in physical activity and alcohol can increase the risk of hypoglycaemia.
• Blood glucose monitoring is important; a clinician may also arrange HbA1c and other checks.
• Low or high blood glucose can impair concentration and affect driving or machinery use.

Additional Precautions

• Pregnancy, plans for pregnancy and breastfeeding call for a treatment review with a healthcare professional.
• Illness, fever, surgery or a substantial change in routine may alter blood glucose control and treatment needs.
• Older people and those who have difficulty recognising low blood glucose may need particular attention to monitoring.
• Glucose-6-phosphate dehydrogenase deficiency should be discussed with a clinician because sulfonylureas can be associated with haemolytic anaemia.
• The inactive ingredients of the supplied tablets have not been verified. Ask a pharmacist to check them if an allergy or intolerance is relevant.

Storage Instructions

• Follow the storage directions on the supplied pack; exact requirements for these tablets have not been verified.
• Keep tablets in their original packaging so their name, strength and expiry date remain identifiable.
• Keep all medicines out of the reach of children.
• Ask a pharmacist how to dispose of expired or unwanted tablets.

How to Take

• Follow the prescribing healthcare professional’s directions and the label supplied with the medicine.
• The treatment plan should account for meals, blood glucose results and other medicines.
• Do not change a prescribed dose or schedule based on the 1 mg tablet strength alone.
• If a dose is missed, check the supplied medicine information or ask a healthcare professional. Do not make up for it by taking extra tablets.
• Ask a healthcare professional for product-specific guidance if instructions for handling the tablets are unclear.

Drug Interactions

• Other diabetes medicines, including insulin, can increase the risk of hypoglycaemia when combined with glimepiride.
• Fluconazole, some antibiotics and salicylates may increase its blood glucose lowering effect.
• Corticosteroids, thiazide diuretics and rifampicin may reduce its effect, allowing blood glucose to rise.
• Beta blockers can make some warning signs of hypoglycaemia less noticeable.
• Alcohol may increase or decrease glimepiride’s blood glucose lowering action unpredictably.

This is not a complete interaction list. A doctor or pharmacist should review all prescription medicines, over-the-counter products and supplements together.

Why Choose This Product?

• It provides an oral tablet with a stated glimepiride strength of 1 mg.
• Glimepiride has an established role in lowering blood glucose in type 2 diabetes.
• The stated ingredient and strength allow comparison with a healthcare professional’s prescription.

Whether this product is appropriate depends on the individual treatment plan and the supplied product details. Ask a healthcare professional for product-specific guidance.

Frequently Asked Questions (FAQs)

What is the active ingredient?

The active ingredient is glimepiride, stated at 1 mg per tablet.

What type of medicine is glimepiride?

It is a sulfonylurea that lowers blood glucose mainly by stimulating insulin release.

What condition is it used for?

Glimepiride is used for type 2 diabetes when lifestyle measures alone do not provide adequate blood glucose control.

Can it be used for type 1 diabetes?

No. Glimepiride is not a treatment for type 1 diabetes or diabetic ketoacidosis.

What is the main safety concern?

Low blood glucose, or hypoglycaemia, is a key concern and can sometimes be severe.

Can it be combined with other diabetes medicines?

Combination treatment is sometimes used under clinical supervision because it can increase the risk of hypoglycaemia.

Does the 1 mg strength tell me how much to take?

No. It identifies the active ingredient content of each tablet. Individual dosing follows a clinician’s directions.

What if I am pregnant or breastfeeding?

Discuss treatment with a healthcare professional. Glimepiride may not be appropriate during pregnancy or breastfeeding.

How should these tablets be stored?

Follow the supplied pack’s directions and ask a pharmacist if they are missing or unclear.